Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression

Abstract Chronic neuroinflammation with sustained microglial activation occurs in Parkinson’s disease (PD), yet the mechanisms and exact contribution of these cells to the neurodegeneration remains poorly understood. In this study, we induced progressive dopaminergic neuron loss in mice via rAAV-hSY...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhen Zhang, Kun Niu, Taoying Huang, Jiali Guo, Gongbikai Xarbat, Xiaoli Gong, Yunke Gao, Feiyang Liu, Shan Cheng, Wenting Su, Fei Yang, Zhaoyuan Liu, Florent Ginhoux, Ting Zhang
Format: Article
Language:English
Published: Nature Portfolio 2025-01-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-024-00846-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841544876331630592
author Zhen Zhang
Kun Niu
Taoying Huang
Jiali Guo
Gongbikai Xarbat
Xiaoli Gong
Yunke Gao
Feiyang Liu
Shan Cheng
Wenting Su
Fei Yang
Zhaoyuan Liu
Florent Ginhoux
Ting Zhang
author_facet Zhen Zhang
Kun Niu
Taoying Huang
Jiali Guo
Gongbikai Xarbat
Xiaoli Gong
Yunke Gao
Feiyang Liu
Shan Cheng
Wenting Su
Fei Yang
Zhaoyuan Liu
Florent Ginhoux
Ting Zhang
author_sort Zhen Zhang
collection DOAJ
description Abstract Chronic neuroinflammation with sustained microglial activation occurs in Parkinson’s disease (PD), yet the mechanisms and exact contribution of these cells to the neurodegeneration remains poorly understood. In this study, we induced progressive dopaminergic neuron loss in mice via rAAV-hSYN injection to cause the neuronal expression of α-synuclein, which produced neuroinflammation and behavioral alterations. We administered PLX5622, a colony-stimulating factor 1 receptor inhibitor, for 3 weeks prior to rAAV-hSYN injection, maintaining it for 8 weeks to eliminate microglia. This chronic treatment paradigm prevented the development of motor deficits and concomitantly preserved dopaminergic neuron cell and weakened α-synuclein phosphorylation. Gene expression profiles related to extracellular matrix (ECM) remodeling were increased after microglia depletion in PD mice, which were further validated on protein level. We demonstrated that microglia exert adverse effects during α-synuclein-overexpression-induced neuronal lesion formation, and their depletion remodels ECM and aids recovery following insult.
format Article
id doaj-art-222e1c54b30746d2b58c3a500f0b8806
institution Kabale University
issn 2373-8057
language English
publishDate 2025-01-01
publisher Nature Portfolio
record_format Article
series npj Parkinson's Disease
spelling doaj-art-222e1c54b30746d2b58c3a500f0b88062025-01-12T12:12:39ZengNature Portfolionpj Parkinson's Disease2373-80572025-01-0111111610.1038/s41531-024-00846-4Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpressionZhen Zhang0Kun Niu1Taoying Huang2Jiali Guo3Gongbikai Xarbat4Xiaoli Gong5Yunke Gao6Feiyang Liu7Shan Cheng8Wenting Su9Fei Yang10Zhaoyuan Liu11Florent Ginhoux12Ting Zhang13Department of Neurobiology, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory on Parkinson Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical UniversityDepartment of Neurobiology, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory on Parkinson Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical UniversityDepartment of Neurobiology, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory on Parkinson Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical UniversityDepartment of Neurobiology, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory on Parkinson Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical UniversityDepartment of Neurobiology, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory on Parkinson Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical UniversityDepartment of Physiology and Pathophysiology, Capital Medical UniversityDepartment of Neurobiology, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory on Parkinson Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical UniversityDepartment of Neurobiology, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory on Parkinson Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical UniversityDepartment of Medical Genetics and Developmental Biology, Capital Medical UniversityBeijing Institute of Brain Disorders, Laboratory of Brain Disorders, Ministry of Science and Technology, Collaborative Innovation Center for Brain Disorders, Capital Medical UniversityDepartment of Neurobiology, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory on Parkinson Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical UniversityShanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of MedicineShanghai Institute of Immunology, Department of Immunology and Microbiology, Shanghai Jiao Tong University School of MedicineDepartment of Neurobiology, Center of Parkinson Disease Beijing Institute for Brain Disorders, Beijing Key Laboratory on Parkinson Disease, Key Laboratory for Neurodegenerative Disease of the Ministry of Education, Beijing Key Laboratory of Neural Regeneration and Repair, Capital Medical UniversityAbstract Chronic neuroinflammation with sustained microglial activation occurs in Parkinson’s disease (PD), yet the mechanisms and exact contribution of these cells to the neurodegeneration remains poorly understood. In this study, we induced progressive dopaminergic neuron loss in mice via rAAV-hSYN injection to cause the neuronal expression of α-synuclein, which produced neuroinflammation and behavioral alterations. We administered PLX5622, a colony-stimulating factor 1 receptor inhibitor, for 3 weeks prior to rAAV-hSYN injection, maintaining it for 8 weeks to eliminate microglia. This chronic treatment paradigm prevented the development of motor deficits and concomitantly preserved dopaminergic neuron cell and weakened α-synuclein phosphorylation. Gene expression profiles related to extracellular matrix (ECM) remodeling were increased after microglia depletion in PD mice, which were further validated on protein level. We demonstrated that microglia exert adverse effects during α-synuclein-overexpression-induced neuronal lesion formation, and their depletion remodels ECM and aids recovery following insult.https://doi.org/10.1038/s41531-024-00846-4
spellingShingle Zhen Zhang
Kun Niu
Taoying Huang
Jiali Guo
Gongbikai Xarbat
Xiaoli Gong
Yunke Gao
Feiyang Liu
Shan Cheng
Wenting Su
Fei Yang
Zhaoyuan Liu
Florent Ginhoux
Ting Zhang
Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
npj Parkinson's Disease
title Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
title_full Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
title_fullStr Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
title_full_unstemmed Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
title_short Microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse Parkinson’s disease model triggered by α-synuclein overexpression
title_sort microglia depletion reduces neurodegeneration and remodels extracellular matrix in a mouse parkinson s disease model triggered by α synuclein overexpression
url https://doi.org/10.1038/s41531-024-00846-4
work_keys_str_mv AT zhenzhang microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT kunniu microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT taoyinghuang microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT jialiguo microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT gongbikaixarbat microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT xiaoligong microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT yunkegao microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT feiyangliu microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT shancheng microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT wentingsu microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT feiyang microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT zhaoyuanliu microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT florentginhoux microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression
AT tingzhang microgliadepletionreducesneurodegenerationandremodelsextracellularmatrixinamouseparkinsonsdiseasemodeltriggeredbyasynucleinoverexpression